Prospective Study of a Pediatric Nifurtimox Formulation for Chagas' Disease

Mise à jour : Il y a 4 ans
Référence : NCT02625974

Femme et Homme

Extrait

This study was designed to develop a better understanding of the efficacy, safety/tolerability, and pharmacokinetics (PK) (absorption, distribution, metabolism, and elimination) of nifurtimox in children with a diagnosis of Chagas' disease (Trypanosoma cruzi infection) using pediatric formulations.


Critère d'inclusion

  • Chagas' disease

Liens